UBS raised the firm’s price target on Nutrien (NTR) to $64 from $56 and keeps a Neutral rating on the shares. The firm continues to expect medium-term declines across NPK pricing, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTR:
- Nutrien price target raised to $62 from $59 at Wells Fargo
- Nutrien price target raised to $70 from $65 at RBC Capital
- CoreWeave initiated, Texas Instruments upgraded: Wall Street’s top analyst calls
- Nutrien downgraded to Hold from Buy at Jefferies
- Nutrien’s Short-term Gains and Long-term Challenges: A Hold Rating Amid Supply Disruptions and Structural Headwinds